The role of cAMP and calcium in the induction of ornithine decarboxylase (ODC, E.C.4.1 .I .I 7) activity in the osteogenic sarcoma cell line, UMR 106-01, was studied, with particular interest for parathyroid hormone (PTH). PTH and forskolin dose-dependently induced the ODC activity and the cAMP prod
Modulatory function of protein kinase C in the activation of ornithine decarboxylase and in cAMP production in rat osteoblasts
β Scribed by J. P. T. M. van Leeuwen; M. P. Bos; M. P. M. Herrmann-Erlee
- Publisher
- John Wiley and Sons
- Year
- 1989
- Tongue
- English
- Weight
- 680 KB
- Volume
- 138
- Category
- Article
- ISSN
- 0021-9541
No coin nor oath required. For personal study only.
β¦ Synopsis
The effect of activation of protein kinase C on stimulation of ornithine decarboxylase (ODC) activity and cAMP production was studied in fetal rat osteoblasts. Both phorbol 1 Zmyristate, 1 :<-acetate (PMA), an activator of protein kinase C, and 4cr-phorb01, ineffective in activating protein kinase C, failed to stimulate ODC activity and cAMP production. We tested the effect of protein kinase C on stimulation of ODC activity by parathyroid hormone (PTH) and forskolin. In contrast to PTH-stimulated ODC activity, which was not affected by PMA, forskolin-stimulated (1 and 10 pM) ODC activity was dose dependently reduced.
PMA (400 nM) reduced both 1 and 10 FM forskolin-stimulated ODC activity to the same level, -3 nmol CO,/rng protein, which suggests a controlling role of protein kinase C in forskolin-stimulated ODC activity. The study of the effect of protein kinase C on PTH-and forskolin-stimulated cAMP production also revealed differences between PTH and forskolin. When PMA was added simultaneously with PPH (4 and 20 nM) or forskolin (1 and 10 pM) the PTH-stimulated cAMP production was dose-dependently potentiated by PMA, whereas forskolinstimulated cAMP production was not affected. However, both PIHand forskolin-stimulated CAMP production was dose-dependently augmented when PMA was added 3 min prior to PTH or forskolin. With increasing preincubation periods (up to 24 h) with PMA instead of a potentiation an inhibition was observed. Thi5 inhibition is not due to PTH receptor desensitization, although, on basis of the present results desensitization can not completely be excluded. In all cases 4a-phorbol was without effect. The present results show that protein kinase C modulates stimulation of ODC activity and cAMP production in fetal rat osteoblasts. The modulation of both ODC activity and CAMP production appears to be dependent on the nature of the stimulator. The present data suggest a role for protein kinase C in limiting the CAMP-mediated stimulation of ODC activity in these cells. Furthermore, it is suggested that protein kinase C can interfere at more than one site in the CAMP-generating system.
π SIMILAR VOLUMES
## Abstract Cultures of rat C6 rat glioma cells exhibit a diminished response to isoproterenol and forskolin after being treated with phorbol 12,13βdibutyrate (PDbU). An IC50 for PDbU of 38Β±5 nM and 62Β±8 nM was observed in the isoproternol and forskolin response, respectively. Similarly, C6 culture
nases. These results suggest that PTK, Ras, and PKC Hepatocyte growth factor (HGF) stimulated mitogenplay roles in MAP kinase activation induced by HGF and activated protein (MAP) kinases and MAP kinase kinase that MAP kinase activation resulting in AA release is in primary cultured rat hepatocytes.
In this study we examined the action of phorbol esters, several phospholipases and retinoids on t h e induction of ornithine decarboxylase (ODC) activity in rat tracheal epithelial cells. 12-0-Tetradecanoylphorbol-13-acetate (TPA) induces ODC activity in these cells in a dose-and time-dependent mann
## Abstract The phorbol ester receptor protein kinase C (PKC) gene family encodes essential mediators of various eukaryotic cellular signals. The molecular dissection of its mechanisms of action has been limited in part by the genetic inaccessibility and complexity of signaling in mammalian cells.
The cell line A126-1B2 is a PC12-derived mutant that is resistant to the toxic effects of dibutyryladenosine 3'5'-cyclic monophosphate (dbcAMP) and is deficient in adenosine 3':5'-cyclic monophosphate (CAMP)-dependent protein kinase I1 (PKAII). This mutant formed neurites in response to nerve growth